Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Mar 4;11(2):196-204.
doi: 10.1080/19336918.2017.1279784. Epub 2017 Feb 1.

The isolation of morphologically intact and biologically active extracellular vesicles from the secretome of cancer-associated adipose tissue

Affiliations

The isolation of morphologically intact and biologically active extracellular vesicles from the secretome of cancer-associated adipose tissue

Sarah Jeurissen et al. Cell Adh Migr. .

Abstract

Breast cancer cells closely interact with different cell types of the surrounding adipose tissue to favor invasive growth and metastasis. Extracellular vesicles (EVs) are nanometer-sized vesicles secreted by different cell types that shuttle proteins and nucleic acids to establish cell-cell communication. To study the role of EVs released by cancer-associated adipose tissue in breast cancer progression and metastasis a standardized EV isolation protocol that obtains pure EVs and maintains their functional characteristics is required. We implemented differential ultracentrifugation as a pre-enrichment step followed by OptiPrep density gradient centrifugation (dUC-ODG) to isolate EVs from the conditioned medium of cancer-associated adipose tissue. A combination of immune-electron microscopy, nanoparticle tracking analysis (NTA) and Western blot analysis identified EVs that are enriched in flotillin-1, CD9 and CD63, and sized between 20 and 200 nm with a density of 1.076-1.125 g/ml. The lack of protein aggregates and cell organelle proteins confirmed the purity of the EV preparations. Next, we evaluated whether dUC-ODG isolated EVs are functionally active. ZR75.1 breast cancer cells treated with cancer-associated adipose tissue-secreted EVs from breast cancer patients showed an increased phosphorylation of CREB. MCF-7 breast cancer cells treated with adipose tissue-derived EVs exhibited a stronger propensity to form cellular aggregates. In conclusion, dUC-ODG purifies EVs from conditioned medium of cancer-associated adipose tissue, and these EVs are morphologically intact and biologically active.

Keywords: aggregation; breast cancer; characterization; exosomes; function; isolation; proliferation.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Schematic overview of the dUC-ODG protocol to isolate EVs from cancer-associated adipose tissue-derived conditioned medium (CMCAAT). Approximately 21 g of CAAT was ex vivo cultivated in control medium. CMCAAT was harvested, centrifuged and used for further isolation by a combination of differential ultracentrifugation followed by Optiprep density gradient centrifugation.
Figure 2.
Figure 2.
Protein analysis of (non) EV-enriched proteins. EVs were isolated from the conditioned medium of cancer-associated adipose tissue by the dUC-ODG protocol. Western blot analysis of (A) EV-enriched proteins (flotillin-1, CD9 and HSP70) and adipocyte-specific protein FABP-4 and (B) cell organelle and apoptotic body proteins (GM130, prohibitin and calreticulin).
Figure 3.
Figure 3.
Morphological characterization and quantification of EV preparations by electron microscopy (EM) and nanoparticle tracking analysis (NTA). EVs were isolated from the conditioned medium of cancer-associated adipose tissue by the dUC-ODG protocol. (A) Left: Wide-field EM picture of EVs of fractions 8–9 fsrom the density gradient corresponding to the density of 1.086–1.103 g/ml. Scale bar: 200 nm. Right: Zoom in on CD63-positive and negative EVs. (B) The calculated size distribution of EVs analyzed by NTA depicted as a mean (black line) with standard error (red shaded area). Total particle number, mean particle size and modus are shown.
Figure 4.
Figure 4.
Stimulation of CREB transcription factor phosphorylation and sphere formation by EVs. EVs were isolated from the conditioned medium of cancer-associated adipose tissue by the dUC-ODG protocol. (A) Western blot analysis of phospho-CREB and total CREB from lysates of ZR75.1 cells under control conditions or treated by 1×108 EVs. (B) The number of aggregates formed by MCF7 single cells seeded in ultra-low attachment plates under control conditions or treated by 5×109 EVs for 24h. Each experiment was performed in quadruplicate.

Similar articles

Cited by

  • Influence of species and processing parameters on recovery and content of brain tissue-derived extracellular vesicles.
    Huang Y, Cheng L, Turchinovich A, Mahairaki V, Troncoso JC, Pletniková O, Haughey NJ, Vella LJ, Hill AF, Zheng L, Witwer KW. Huang Y, et al. J Extracell Vesicles. 2020 Jun 30;9(1):1785746. doi: 10.1080/20013078.2020.1785746. J Extracell Vesicles. 2020. PMID: 32944174 Free PMC article.
  • Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches.
    Welsh JA, Goberdhan DCI, O'Driscoll L, Buzas EI, Blenkiron C, Bussolati B, Cai H, Di Vizio D, Driedonks TAP, Erdbrügger U, Falcon-Perez JM, Fu QL, Hill AF, Lenassi M, Lim SK, Mahoney MG, Mohanty S, Möller A, Nieuwland R, Ochiya T, Sahoo S, Torrecilhas AC, Zheng L, Zijlstra A, Abuelreich S, Bagabas R, Bergese P, Bridges EM, Brucale M, Burger D, Carney RP, Cocucci E, Crescitelli R, Hanser E, Harris AL, Haughey NJ, Hendrix A, Ivanov AR, Jovanovic-Talisman T, Kruh-Garcia NA, Ku'ulei-Lyn Faustino V, Kyburz D, Lässer C, Lennon KM, Lötvall J, Maddox AL, Martens-Uzunova ES, Mizenko RR, Newman LA, Ridolfi A, Rohde E, Rojalin T, Rowland A, Saftics A, Sandau US, Saugstad JA, Shekari F, Swift S, Ter-Ovanesyan D, Tosar JP, Useckaite Z, Valle F, Varga Z, van der Pol E, van Herwijnen MJC, Wauben MHM, Wehman AM, Williams S, Zendrini A, Zimmerman AJ; MISEV Consortium; Théry C, Witwer KW. Welsh JA, et al. J Extracell Vesicles. 2024 Feb;13(2):e12404. doi: 10.1002/jev2.12404. J Extracell Vesicles. 2024. PMID: 38326288 Free PMC article.
  • Prospects and challenges of tissue-derived extracellular vesicles.
    Lee JC, Ray RM, Scott TA. Lee JC, et al. Mol Ther. 2024 Sep 4;32(9):2950-2978. doi: 10.1016/j.ymthe.2024.06.025. Epub 2024 Jun 22. Mol Ther. 2024. PMID: 38910325 Free PMC article. Review.
  • Hitting the Bullseye: Are extracellular vesicles on target?
    Noren Hooten N, Yáñez-Mó M, DeRita R, Russell A, Quesenberry P, Ramratnam B, Robbins PD, Di Vizio D, Wen S, Witwer KW, Languino LR. Noren Hooten N, et al. J Extracell Vesicles. 2020 Nov;10(1):e12032. doi: 10.1002/jev2.12032. Epub 2020 Nov 29. J Extracell Vesicles. 2020. PMID: 33708359 Free PMC article. No abstract available.
  • Proteomic profiling of tumour tissue-derived extracellular vesicles in colon cancer.
    Cvjetkovic A, Karimi N, Crescitelli R, Thorsell A, Taflin H, Lässer C, Lötvall J. Cvjetkovic A, et al. J Extracell Biol. 2024 Feb 6;3(2):e127. doi: 10.1002/jex2.127. eCollection 2024 Feb. J Extracell Biol. 2024. PMID: 38939898 Free PMC article.

References

    1. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144(5):646-74; PMID:21376230; http://dx.doi.org/10.1016/j.cell.2011.02.013 - DOI - PubMed
    1. Lapeire L, Denys H, Cocquyt V, De Wever O. When fat becomes an ally of the enemy: adipose tissue as collaborator in human breast cancer. Horm Mol Biol Clin Investig 2015; 23(1):21-38; PMID:26154196; http://dx.doi.org/10.1515/hmbci-2015-0018 - DOI - PubMed
    1. Lapeire L, Hendrix A, Lambein K, Van Bockstal M, Braems G, Van Den Broecke R, Limame R, Mestdagh P, Vandesompele J, Vanhove C, et al.. Cancer-associated adipose tissue promotes breast cancer progression by paracrine oncostatin M and Jak/STAT3 signaling. Cancer Res 2014; 74(23):6806-19; PMID:25252914; http://dx.doi.org/10.1158/0008-5472.CAN-14-0160 - DOI - PubMed
    1. Dirat B, Bochet L, Dabek M, Daviaud D, Dauvillier S, Majed B, Wang YY, Meulle A, Salles B, Le Gonidec S, et al.. Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. Cancer Res 2011; 71(7):2455-65; PMID:21459803; http://dx.doi.org/10.1158/0008-5472.CAN-10-3323 - DOI - PubMed
    1. Hendrix A, Hume AN. Exosome signaling in mammary gland development and cancer. Int J Dev Biol 2011; 55(7–9):879-87; PMID:22161843; http://dx.doi.org/10.1387/ijdb.113391ah - DOI - PubMed